Global Registries And Surveys Programme - Heart Failure Snapshot Study (GRASP-HF)

European Society of Cardiology0 sites4,000 target enrollmentSeptember 2024

ConditionsHeart Failure

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Heart Failure
Sponsor: European Society of Cardiology
Enrollment: 4000
Primary Endpoint: Adherence to ESC Guidelines in Heart Failure 2021
Status: Not yet recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

The goal of this observational study is to provide a better understanding of medical practice for heart failure management based on real-world data, collected both across Europe and the rest of the world, using robust methodology and representativeness within each country.

Standard management of patients will be the diagnostic and therapeutic interventions routinely performed in each center for patients presenting with signs and symptoms of chronic/acute heart failure.

Registry

clinicaltrials.gov

Start Date

September 2024

End Date

June 2025

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

European Society of Cardiology

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Adult patients with chronic or acute Heart Failure (HF), regardless of ejection fraction, either:
•Outpatient with chronic HF (including first-time diagnosis), according to the clinical judgment.
•Patients admitted to hospital or presenting to Emergency Department or Acute out-patient care for acute HF for whom an IV (diuretics, inotropes, vasodilators) or mechanical therapy for HF (mechanical circulatory support) is administered.

Exclusion Criteria

•Age \<18 years
•Patients unwilling to consent (or patient's legally authorized representative unwilling to consent, if the patient is unable to consent).